Whalatane
Re: rosemountbomber post# 29
Monday, January 10, 2022 1:55:14 PM
Post# of 109
Bomber ...KOD presenting at JPM today
Baker Bros still own almost 30% of the Co from what I can tell ...last purchase at $93 a share !
I was stopped out of half my position in the 80's and have resigned myself to holding the remainder thru data read out Feb/March .
Oiy
Kiwi
Stopped out of half in the $80's . Don't remember how bad that loss was ...but back in under $9 I think.
Whalatane
Re: Whalatane post# 91
Tuesday, August 19, 2025 2:25:04 PM
Post# of 110
So note to myself ...down 18% as I type to around $9
Will add some
Co will need $ but has a lot of readouts thru 2026 ...so worth at least some speculative $
JMO
Kiwi
Baker Bros just bet another $60m on this ...So I guess I'm along for the ride and trying to get you , Canes , Fred , Ernie et al to join me :--)
Major Insider Purchase:
A key director, Bros. Advisors LP Baker, acquired over 2.6 million shares at a price of $23.00 per share in a transaction reported on December 18, 2025, a purchase valued at approximately $60 million.
Kiwi
Recent KOD News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:35:12 PM
- Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 • PR Newswire (US) • 02/04/2026 12:00:00 PM
- Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/08/2026 01:19:00 AM
- Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 12/19/2025 01:26:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 09:25:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/17/2025 10:27:33 PM
- Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock • PR Newswire (US) • 12/17/2025 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/15/2025 10:12:27 PM
- Kodiak Sciences Announces Proposed Public Offering of Common Stock • PR Newswire (US) • 12/15/2025 09:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:12:38 PM
- Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results • PR Newswire (US) • 11/13/2025 09:05:00 PM
- Kodiak Sciences to Present at Upcoming Investor Conferences • PR Newswire (US) • 11/12/2025 10:48:00 PM
- Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI) • PR Newswire (US) • 11/05/2025 12:00:00 PM
- New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI) • PR Newswire (US) • 09/15/2025 11:00:00 AM
- Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI) • PR Newswire (US) • 09/02/2025 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/19/2025 09:26:43 PM
- Kodiak Sciences to Present at American Chemical Society Fall 2025 • PR Newswire (US) • 08/19/2025 06:18:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 08:11:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:00:37 PM
- Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results • PR Newswire (US) • 08/13/2025 08:00:00 PM
- Kodiak Sciences to Host Investor R&D Day on July 16, 2025 • PR Newswire (US) • 07/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:33:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:30:46 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
